Therascreen EGFR RGQ Plasma PCR regulatory update

Qiagen said it received CE Mark approval for therascreen EGFR RGQ Plasma PCR kit to identify EGFR mutations in patients with non-small cell lung cancer (NSCLC). Qiagen and AstraZeneca co-developed the...